|
Loriga, Giovanni and Ruiu, Stefania and Manca, Ilaria and Murineddu, Gabriele and Dessì, Christian and Pani, Luca and Pinna, Gérard Aimé (2007) 3-{2-[Bis-(4-fluorophenyl)methoxy]ethyl}-6-substituted-3,6-diazabicyclo[3.1.1]heptanes as novel potent dopamine uptake inhibitors. Bioorganic & Medicinal Chemistry, Vol. 15 (11), p. 3748-3755. eISSN 1464-3391. Article. Full text not available from this repository. DOI: 10.1016/j.bmc.2007.03.035 AbstractA series of analogues 2a–i related to 3-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-8-(1H-indol-2-ylmethyl)-3,8-diazabicyclo[3.2.1]octane (1) in which the 3,8-diazabicyclo[3.2.1]octane core was replaced by 3,6-diazabicyclo[3.1.1]heptane ring system has been synthesized and evaluated for their ability to inhibit DA reuptake into striatal nerve endings (synaptosomes). Biological data showed that compound 2a, the closest analogue of lead 1, possessed an increased reuptake inhibition activity over 1 (2a, Ki = 5.5 nM). Replacement of the indole ring with bioisosteric aromatic rings—benzothiophene (2b), benzofurane (2c), or indene (2d)—resulted, with the exception of 2d, in a double digit nanomolar activity. Changing the indenyl moiety of 2d with simplified aryl groups led to compounds 2e–h which displayed a similar or slightly decreased activity with respect to the ground term. Naphthalene derivative (2i) demonstrated a weaker activity than aromatic analogues.
I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore Repository Staff Only: item control page |


